Contact skin radiotherapy (brachytherapy) for the treatment of non‐melanoma skin cancers during COVID ‐19 pandemic
- 19 December 2021
- journal article
- research article
- Published by Wiley in Dermatologic Therapy
- Vol. 35 (3) , e15276
Abstract
In the context of the SARS-CoV-2 pandemic, it is important to ensure the quality of cancer treatment as well as patients and health professionals' safety. Individual-based treatment options should be considered in patients with advanced epithelial skin cancer, who are typically elderly and frail. Aim of this study was to assess feasibility and safety of Contact Skin Radiation Therapy (CSRT) to treat basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) during SARS-CoV-2 pandemic. Patients with advanced and difficult-to-treat BCC or SCC were discussed at skin multidisciplinary tumor board (S-MDTB) from February the 21st to May the 4th (phase 1 Italian Pandemic) and retrospectively analyzed. Patient's triage following internal recommendations was daily performed. CSRT was delivered in 8 fractions of 5 Gy each, twice a day. Beyond the clinical outcomes, treatment success indicators, such as the completion of CSRT without SARS-COV-2 occurrence, were identified to evaluate the feasibility of CSRT during pandemic. A post-treatment psychological assessment regarding patient's safety perception was performed. Six male patients (median age 80 years; range 62–92) with histologically confirmed BCC or SCC were treated with CSRT. Complete clinical remission was achieved in 5/6 patients (83.4%). No high-grade acute toxicities occurred during treatment. No patients or healthcare personnel developed SARS-Cov-2 infection. All the treatment success indicators were achieved. CSRT represents a safe, and feasible treatment option even during the pandemic emergency period. Hypofractionation could be an option to reduce total number of fractions and, consequently, infective risk exposition.Keywords
This publication has 39 references indexed in Scilit:
- Hypofractionated high-dose-rate plesiotherapy in nonmelanoma skin cancer treatmentBrachytherapy, 2015
- Brachytherapy in non melanoma skin cancer of eyelid: a systematic reviewJournal of Contemporary Brachytherapy, 2015
- Brachytherapy in the treatment of skin cancer: an overviewAdvances in Dermatology and Allergology, 2015
- Non-melanoma skin cancer treated with HDR Valencia applicator: clinical outcomesJournal of Contemporary Brachytherapy, 2014
- HDR Brachytherapy for Superficial Non‐Melanoma Skin CancersJournal of Medical Imaging and Radiation Oncology, 2012
- Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of responseJournal of the European Academy of Dermatology and Venereology, 2010
- Dermatological high-dose-rate brachytherapy for the treatment of basal and squamous cell carcinomaClinical and Experimental Dermatology, 2008
- HDR Brachytherapy with Standardized Surface Applicators in the Treatment of Superficial Malignant Skin LesionsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Quality of life assessment in women with breast cancer: benefits, acceptability and utilizationHealth and Quality of Life Outcomes, 2007
- High dose-rate microselectron molds in the treatment of skin tumorsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995